New medical manufacturing site to produce precision extruded tubing for minimally invasive neurovascular and cardiovascular devices
Lubrizol, a global specialty chemicals leader, and Polyhose, a leading manufacturer in fluid conveyance systems, have inaugurated a new medical manufacturing site in Chennai, Tamil Nadu. The facility will manufacture precision extruded medical tubing for minimally invasive devices, supporting India’s rapidly growing medical technology and healthcare sectors.
Designed as a world-class operation, the ISO13485 facility provides customers with a reliable source of high-quality medical tubing, backed by dedicated quality control and the same rigorous standards applied across Lubrizol’s global manufacturing network. This investment strengthens Lubrizol’s ability to serve customers in India and across global markets.
Operations focus on delivering precision extruded tubing from a wide range of high-performance materials, including polyamides, nylon, Pebax®, polypropylene, polyethylene, and Lubrizol’s medical grade thermoplastic polyurethane (TPU).
Abhishek Shrivastava, Managing Director, Lubrizol IMEA said, "India is a strategic growth market for Lubrizol and a key hub for our investments in manufacturing, R&D and technical services. This medical manufacturing site in Chennai is another step in building a stronger local ecosystem for high-value, technology-driven products. By working closely with Polyhose and regional stakeholders, we aim to support innovation, create high-skilled jobs and enable India to become a more significant contributor to the global medical device supply chain."
The new site is set to expand India’s capacity for precision extruded medical tubing, contributing to the country’s focus on building domestic medical device manufacturing capabilities, reducing reliance on imports, and enhancing patient access to high-quality, safe product.
Published on : 22nd June, 2026